Karan Kumar

667 total citations
30 papers, 310 citations indexed

About

Karan Kumar is a scholar working on Hepatology, Epidemiology and Pharmacology. According to data from OpenAlex, Karan Kumar has authored 30 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hepatology, 14 papers in Epidemiology and 5 papers in Pharmacology. Recurrent topics in Karan Kumar's work include Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (8 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Karan Kumar is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Liver Disease and Transplantation (8 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). Karan Kumar collaborates with scholars based in India, United States and Chile. Karan Kumar's co-authors include Anand V. Kulkarni, Mithun Sharma, D. Nageshwar Reddy, Madhumita Premkumar, Padaki Nagaraja Rao, Harsh Vardhan Tevethia, A. K. Mukhopadhyay, Arulselvi Subramanian, Juan Pablo Arab and Roberto Cândia and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The American Journal of Gastroenterology.

In The Last Decade

Karan Kumar

27 papers receiving 303 citations

Peers

Karan Kumar
Kassahun Haile Ethiopia
Y White United Kingdom
Anshuman Elhence India
E. Scheuermann Germany
Valentina Cossiga Italy
Knut Stokkeland Sweden
Rehab Badawi Egypt
Nasir Khokhar Pakistan
Carla W. Brady United States
Jeremy Louissaint United States
Kassahun Haile Ethiopia
Karan Kumar
Citations per year, relative to Karan Kumar Karan Kumar (= 1×) peers Kassahun Haile

Countries citing papers authored by Karan Kumar

Since Specialization
Citations

This map shows the geographic impact of Karan Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karan Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karan Kumar more than expected).

Fields of papers citing papers by Karan Kumar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karan Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karan Kumar. The network helps show where Karan Kumar may publish in the future.

Co-authorship network of co-authors of Karan Kumar

This figure shows the co-authorship network connecting the top 25 collaborators of Karan Kumar. A scholar is included among the top collaborators of Karan Kumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karan Kumar. Karan Kumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kulkarni, Anand V., Karan Kumar, Suprabhat Giri, et al.. (2025). Infections in Standard or Tapered Dose of Prednisolone for Alcohol-Associated Hepatitis: A Randomized Trial (STASH Trial). The American Journal of Gastroenterology. 120(12). 2821–2831. 1 indexed citations
2.
Kumar, Karan, Anand V. Kulkarni, Vinod Arora, et al.. (2025). Predictors of Non-response to Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma: A Multicentre Real World Study (HCC-AB Study). Journal of Clinical and Experimental Hepatology. 15(4). 102513–102513. 1 indexed citations
3.
Kumar, Karan, et al.. (2025). Gender Diversity on Boards and Sustainability: A Bibliometric Review. SSRN Electronic Journal.
4.
Roy, A. D., Karan Kumar, Madhumita Premkumar, et al.. (2024). Current status of etiology and outcomes of acute liver failure in India—A multicentre study from tertiary centres. Indian Journal of Gastroenterology. 44(1). 47–56. 3 indexed citations
5.
Kulkarni, Anand V., Karan Kumar, Somaya Albhaisi, et al.. (2024). Impact of Karnofsky performance status on outcomes of patients with severe alcohol‐associated hepatitis: a propensity‐matched analysis. Internal Medicine Journal. 55(1). 109–116. 1 indexed citations
6.
Jagdish, Rakesh Kumar, Akash Roy, Karan Kumar, et al.. (2023). Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure. Frontiers in Medicine. 10. 1060073–1060073. 12 indexed citations
7.
Kulkarni, Anand V., Karan Kumar, & Juan Pablo Arab. (2023). Role of Prophylactic Antibiotics in Patients with Severe Alcohol-related Hepatitis. Journal of Clinical and Experimental Hepatology. 13(6). 1146–1148. 2 indexed citations
8.
Kumar, Karan, Ankur Jindal, Ekta Gupta, et al.. (2023). Long Term HBsAg Responses to Peg-Interferon Alpha-2b in HBeAg Negative Chronic Hepatitis B Patients Developing Clinical Relapse after Stopping Long-Term Nucleos(t)ide Analogue Therapy. Journal of Clinical and Experimental Hepatology. 14(1). 101272–101272. 2 indexed citations
9.
Kulkarni, Anand V., Harsh Vardhan Tevethia, Karan Kumar, et al.. (2023). Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis. EClinicalMedicine. 63. 102179–102179. 25 indexed citations
10.
Kulkarni, Anand V., Karan Kumar, Mithun Sharma, et al.. (2023). Safety and Efficacy of Atezolizumab-Bevacizumab in Real World: The First Indian Experience. Journal of Clinical and Experimental Hepatology. 13(4). 618–623. 23 indexed citations
11.
Kumar, Karan, Ankur Jindal, Ashish Kumar Vyas, et al.. (2023). Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN. Hepatology Communications. 7(5). 5 indexed citations
12.
Kumari, Sangeeta, et al.. (2023). Voluntary Non-remunerated Blood Donations: The Reasons for Underrepresentation of Female Gender and the Way Forward. Journal of Postgraduate Medicine Education and Research. 57(1). 1–2. 1 indexed citations
13.
Kulkarni, Anand V., Chetan Kalal, Mithun Sharma, et al.. (2022). Tinospora Cordifolia (Giloy)–Induced Liver Injury During the COVID‐19 Pandemic—Multicenter Nationwide Study From India. Hepatology Communications. 6(6). 1289–1300. 29 indexed citations
14.
Kulkarni, Anand V., Madhumita Premkumar, Juan Pablo Arab, et al.. (2022). Early Diagnosis and Prevention of Infections in Cirrhosis. Seminars in Liver Disease. 42(3). 293–312. 23 indexed citations
15.
Singh, Manjeet, et al.. (2022). Plasma random glucose levels at hospital admission predicting worse outcomes in STEMI patients undergoing PCI: A case series. Annals of Medicine and Surgery. 78. 103857–103857. 3 indexed citations
16.
Kulkarni, Anand V., Harsh Vardhan Tevethia, Madhumita Premkumar, et al.. (2022). Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study. Scientific Reports. 12(1). 5503–5503. 22 indexed citations
17.
Asghar, Muhammad Sohaib, Karan Kumar, Sadia Iqbal, et al.. (2022). Split Dosage Weekly Regimen of Oral Methotrexate is Associated With Improved Side Effect Profile in Rheumatoid Arthritis Patients: A Quasi-experimental Study.. Journal of Community Hospital Internal Medicine Perspectives. 12(4). 35–43. 2 indexed citations
18.
Kulkarni, Anand V., Karan Kumar, Roberto Cândia, et al.. (2021). Prophylactic Perioperative Terlipressin Therapy for Preventing Acute Kidney Injury in Living Donor Liver Transplant Recipients: A Systematic Review and Meta-Analysis. Journal of Clinical and Experimental Hepatology. 12(2). 417–427. 6 indexed citations
19.
Kulkarni, Anand V., Harsh Vardhan Tevethia, Madhumita Premkumar, et al.. (2021). Impact of COVID-19 on liver transplant recipients–A systematic review and meta-analysis. EClinicalMedicine. 38. 101025–101025. 52 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kassahun Haile Breakdown of academic impact, for papers by Y White Breakdown of academic impact, for papers by Anshuman Elhence Breakdown of academic impact, for papers by E. Scheuermann Breakdown of academic impact, for papers by Valentina Cossiga Breakdown of academic impact, for papers by Knut Stokkeland Breakdown of academic impact, for papers by Rehab Badawi Breakdown of academic impact, for papers by Nasir Khokhar Breakdown of academic impact, for papers by Carla W. Brady Breakdown of academic impact, for papers by Jeremy Louissaint
Rankless by CCL
2026